Purpose.

The legislature has recognized that restricting access to ephedrine, pseudoephedrine, and phenylpropanolamine products, or their salts or isomers, or salts of isomers, is a valid method to reduce the availability of these products for the manufacture of methamphetamine. To reduce the use of these products in the manufacture of methamphetamine, while continuing access for legitimate purposes, the legislature directed the board to adopt rules to implement a statewide methamphetamine precursor tracking system for the nonprescription sales of products containing ephedrine, pseudoephedrine or phenylpropanolamine or their salts or isomers, or salts of isomers. This chapter describes the requirements for the retail sales of restricted products.